Revenue
$7.10B
Fiscal year ended 2025-06-30Operating income
Unavailable
Fiscal year ended 2025-06-30Free cash flow
$761.00M
Fiscal year ended 2025-06-30CLOROX CO /DE/ (CLX) reported revenue of $7.10B and net income of $810.00M for the fiscal year ended 2025-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from CLOROX CO /DE/’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.10B | $7.09B | $7.39B | $7.11B | $7.34B | $6.72B | $6.21B | $6.12B | $5.97B | $5.76B |
| Cost of revenue | $3.89B | $4.04B | $4.48B | $4.56B | $4.14B | $3.66B | $3.49B | $3.45B | $3.30B | $3.16B |
| Gross profit | $3.21B | $3.05B | $2.91B | $2.54B | $3.20B | $3.06B | $2.73B | $2.68B | $2.67B | $2.60B |
| Operating income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Net income | $810.00M | $280.00M | $149.00M | $462.00M | $710.00M | $939.00M | $820.00M | $823.00M | $701.00M | $648.00M |
| Research & development | $121.00M | $126.00M | $138.00M | $132.00M | $149.00M | $145.00M | $136.00M | $132.00M | $135.00M | $141.00M |
| Weighted-average diluted shares | shares 124.29M | shares 124.80M | shares 124.18M | shares 123.91M | shares 127.30M | shares 127.67M | shares 129.79M | shares 131.58M | shares 131.57M | shares 131.72M |
| Pretax income | $1.08B | $398.00M | $238.00M | $607.00M | $900.00M | $1.18B | $1.02B | $1.05B | $1.03B | $983.00M |
| Income tax expense | $254.00M | $106.00M | $77.00M | $136.00M | $181.00M | $246.00M | $204.00M | $231.00M | $330.00M | $335.00M |
| Diluted EPS | $6.52 | $2.25 | $1.20 | $3.73 | $5.58 | $7.36 | $6.32 | $6.26 | $5.33 | $4.92 |
| Selling, general & administrative | $1.12B | $1.17B | $1.18B | $954.00M | $1.00B | $969.00M | $856.00M | $837.00M | $810.00M | $806.00M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $167.00M | $202.00M | $367.00M | $183.00M | $319.00M | $871.00M | $111.00M | $131.00M | $418.00M | $401.00M |
| Total assets | $5.56B | $5.75B | $5.94B | $6.16B | $6.33B | $6.21B | $5.12B | $5.06B | $4.57B | $4.51B |
| Current assets | $1.61B | $1.62B | $1.83B | $1.72B | $1.83B | $2.02B | $1.30B | $1.31B | $1.51B | $1.48B |
| Total liabilities | $5.08B | $5.26B | $5.56B | $5.43B | $5.74B | $5.30B | $4.56B | $4.33B | $4.03B | $4.21B |
| Current liabilities | $1.92B | $1.57B | $1.92B | $1.78B | $2.06B | $1.42B | $1.44B | $1.20B | $1.81B | $1.56B |
| Total equity incl. NCI | $482.00M | $492.00M | $388.00M | $729.00M | $592.00M | $908.00M | $559.00M | $726.00M | $542.00M | $297.00M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $523.00M | $637.00M | $696.00M | $755.00M | $752.00M | $454.00M | $512.00M | $506.00M | $459.00M | $443.00M |
| Accounts receivable | $821.00M | $695.00M | $688.00M | $681.00M | $604.00M | $648.00M | $631.00M | $600.00M | $565.00M | $569.00M |
| Goodwill | $1.23B | $1.23B | $1.25B | $1.56B | $1.58B | $1.58B | $1.59B | $1.60B | $1.20B | $1.20B |
| Long-term debt | $2.48B | $2.48B | $2.48B | $2.47B | $2.48B | $2.78B | $2.29B | $2.28B | $1.39B | $1.79B |
| Accounts payable | $838.00M | $950.00M | $1.02B | $960.00M | $930.00M | $575.00M | $507.00M | $507.00M | $501.00M | $490.00M |
Cash flow
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $981.00M | $695.00M | $1.16B | $786.00M | $1.28B | $1.55B | $992.00M | $976.00M | $865.00M | $778.00M |
| Capital expenditures | $220.00M | $212.00M | $228.00M | $251.00M | $331.00M | $254.00M | $206.00M | $194.00M | $231.00M | $172.00M |
| Investing cash flow | -$94.00M | -$175.00M | -$223.00M | -$229.00M | -$452.00M | -$252.00M | -$196.00M | -$859.00M | -$205.00M | -$430.00M |
| Financing cash flow | -$924.00M | -$655.00M | -$753.00M | -$689.00M | -$1.39B | -$523.00M | -$815.00M | -$399.00M | -$645.00M | -$316.00M |
| Net change in cash | -$37.00M | -$161.00M | $182.00M | -$138.00M | -$555.00M | $766.00M | -$21.00M | -$285.00M | $14.00M | $19.00M |
| Stock-based compensation | $81.00M | $74.00M | $73.00M | $52.00M | $50.00M | $50.00M | $43.00M | $53.00M | $51.00M | $45.00M |
| Common dividends paid | $602.00M | $595.00M | $583.00M | $571.00M | $558.00M | $533.00M | $490.00M | $450.00M | $412.00M | $398.00M |
| Common share repurchases | $332.00M | $0 | $0 | $25.00M | $905.00M | $248.00M | $661.00M | $271.00M | $183.00M | $254.00M |
| Depreciation & amortization | $219.00M | $235.00M | $236.00M | $224.00M | $211.00M | $180.00M | $180.00M | $166.00M | $163.00M | $165.00M |
Derived
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $761.00M | $483.00M | $930.00M | $535.00M | $945.00M | $1.29B | $786.00M | $782.00M | $634.00M | $606.00M |
| Gross margin | 45.2% | 43.0% | 39.4% | 35.8% | 43.6% | 45.6% | 43.9% | 43.7% | 44.7% | 45.1% |
| Operating margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| FCF margin | 10.7% | 6.8% | 12.6% | 7.5% | 12.9% | 19.2% | 12.6% | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 1.1% | 1.0% | 1.0% | 0.7% | 0.7% | 0.7% | 0.7% | Unavailable | Unavailable | Unavailable |
| Current ratio | 0.84x | 1.03x | 0.95x | 0.97x | 0.89x | 1.42x | 0.91x | 1.09x | 0.84x | 0.95x |
| Revenue YoY growth | 0.2% | -4.0% | 4.0% | -3.2% | 9.2% | 8.2% | 1.5% | 2.5% | 3.7% | Unavailable |
| Net margin | 11.4% | 3.9% | 2.0% | 6.5% | 9.7% | 14.0% | 13.2% | 13.4% | 11.7% | 11.2% |
| R&D / revenue | 1.7% | 1.8% | 1.9% | 1.9% | 2.0% | 2.2% | 2.2% | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 3.1% | 3.0% | 3.1% | 3.5% | 4.5% | 3.8% | 3.3% | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 5.15x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | 3.15x | Unavailable | Unavailable |
| Effective tax rate | 23.6% | 26.6% | 32.4% | 22.4% | 20.1% | 20.8% | 19.9% | 21.9% | 31.9% | 34.1% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CLX in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-04-30View SEC filing
10-Q · Filed 2026-02-03View SEC filing
10-Q · Filed 2025-11-03View SEC filing
10-K · Filed 2025-08-08View SEC filing
10-Q · Filed 2025-05-05View SEC filing
10-Q · Filed 2025-02-03View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.